microdosing semaglutide for perimenopause and Menopause: Does It Work? GLP-1 Microdosing for Perimenopause and

Key Facts Although the drugs were first approved for Type 2 diabetes maintenance, they were approved for weight loss in recent years, and research has shown they cause significant results: Tirzepatide typically causes patients to lose an average of 22.5% of body fat, while semaglutide causes a 15% reduction

Many telehealth clinics offer compounded semaglutide for as low as $99$299/month, and that often includes free telehealth visits, prescriptions, shipping, and support

Does compounded semaglutide expire if its never been opened

Managing Side Effects Side effects from Semaglutide, such as gastrointestinal issues or hypoglycemia, can be better managed with professional guidance

The key differentiator is the urinary-specific symptoms: burning with urination, frequency, urgency, and changes in urine appearance or smell